Margitta Retz, Marc-Oliver Grimm, Katharina Leucht, Stefanie Zschäbitz. Enfortumab Vedotin und Pembrolizumab. // best practice onkologie. – 2025. – DOI: 10.1007/s11654-025-00663-y. – URL: https://doi.org/10.1007/s11654-025-00663-y
Margitta Retz, Marc-Oliver Grimm, Katharina Leucht, & Stefanie Zschäbitz (2025). Enfortumab Vedotin und Pembrolizumab. best practice onkologie. https://doi.org/10.1007/s11654-025-00663-y
Margitta Retz, et al. “Enfortumab Vedotin und Pembrolizumab.” best practice onkologie, 2025. doi:10.1007/s11654-025-00663-y.
@article{Retz2025,
title = {Enfortumab Vedotin und Pembrolizumab},
author = {Retz, Margitta and Grimm, Marc-Oliver and Leucht, Katharina and Zschäbitz, Stefanie},
journal = {best practice onkologie},
year = {2025},
doi = {10.1007/s11654-025-00663-y},
url = {https://doi.org/10.1007/s11654-025-00663-y}
}